Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 6, 2009, Pages 566-576

  Beltramo, Elena ^a   Berrone, Elena ^a   Tarallo, Sonia ^a   Porta, Massimo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Apoptosis; Bovine retinal pericytes; Diabetic retinopathy; High glucose; Human retinal pericytes; Thiamine

Indexed keywords

BENFOTIAMINE; GLUCOSE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; THIAMINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA FRAGMENTATION; DRUG MECHANISM; HUMAN; HUMAN CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA CELL; SPECIES DIFFERENCE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CATTLE; CELL LINE; CELLS, CULTURED; DIABETIC RETINOPATHY; DNA FRAGMENTATION; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; HYPERGLYCEMIA; IN SITU NICK-END LABELING; MODELS, BIOLOGICAL; OSMOTIC PRESSURE; PERICYTES; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINAL VESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIES SPECIFICITY; STATISTICS, NONPARAMETRIC; THIAMINE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350582646     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.996     Document Type: Article

References (39)

1. DCCT: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512-523.
4. Hammes HP. Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005; 37: 39-43.
5. Porta M, Molinatti PA, Dosso A, Williams FMK, Brooks RA, Kohner EM. Growth of bovine retinal pericytes and endothelial cells in high hexose concentrations. Diabetes Metab 1994; 20: 25-30. (Pubitemid 24232587)
6. Beltramo E, Berrone E, Buttiglieri S, Porta M. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose. Diabetes Metab Res Rev 2004; 20: 330-336. (Pubitemid 39077484)
7. Li W, Liu X, Yanoff M, Cohen S, Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia 1996; 39: 537-547. (Pubitemid 26135457)
8. Li W, Liu X, He Z, Yanoff M, Jian B, Ye X. Expressionof apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. Invest Ophtalmol Vis Sci 1998; 39: 1535-1543. (Pubitemid 28361313)
9. Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab 2001; 281: E924-E930. (Pubitemid 33123798)
10. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis relate to oxidative stress in human umbilical vein endothelial cells. Diabetes 2003; 52: 2795-2804.
11. Piconi L, Quagliaro L, Assaloni R, et al.Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev 2006; 22: 198-203. (Pubitemid 43805400)
12. El-Osta A, Brasacchio D, Yao D, et al.Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205: 2409-2417.
13. Beltramo E, Berrone E, Tarallo S, Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol 2008; 45: 131-141.
14. Agardh CD, Hultberg B, Nayak RC, Farthing-Nayak P, Agardh E. Bovine retinal pericytes are resistant to glucose-induced oxidative stress in vitro. Antioxid Redox Signal 2005; 7: 1486-1493. (Pubitemid 41767984)
15. Miller AG, Smith DG, Bhat M, Hagaraj RH. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem 2006; 2281: 11864-11871. (Pubitemid 43855447)
16. Berrone E, Beltramo E, Tarallo S, Porta M. Establishment and characterization of a human retinal pericyte line: A novel tool for the study of diabetic retinopathy. Int J Mol Med 2009; 23: 373-378.
17. Brignardello E, Beltramo E, Molinatti PA, et al. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol 1998; 158: 21-26. (Pubitemid 28322506)
18. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005; 16: 705-713.
19. Hirschi KK, D'Amore PA. Pericytes in the microvasculature. Cardiovasc Res 1996; 32: 687-698.
20. Ihnat MA, Thorpe JE, Kamat CD, et al.Reactive oxygen species mediate a cellular "memory" of high glucose stress signalling. Diabetologia 2007; 50: 1523-1531.
21. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988; 82: 735-738. (Pubitemid 18213781)
22. Roy S, Sala R, Cagliero E, Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 1990; 87: 404-408. (Pubitemid 20033079)
23. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence. Diabetologia 2001; 44: 2107-2114. (Pubitemid 34015463)
24. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23(suppl. 2): B21-B29. (Pubitemid 30185774)
25. Van Ballegooie E, Hooymans JM, Timmerman Z, et al.Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion. Diabetes Care 1984; 7: 236-242. (Pubitemid 14105304)
26. Dandona P, Bolger JP, Boag F, Fonesca V, Abrams JD. Rapid development and progression of proliferative retinopathy after strict diabetic control. Br Med J 1985; 290: 885-896. (Pubitemid 15110882)
27. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenages O. Rapid tightening of blood glucose levels leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus. Br Med J 1985; 290: 811-815. (Pubitemid 15111977)
28. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycaemic control. Diabetes 1987; 36: 808: 812.
29. Podestà F, Romeo G, Liu WH, et al.Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 2000; 156: 1025-1032. (Pubitemid 30626960)
30. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326. (Pubitemid 28406819)
31. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factor-kappa B induced by diabetes and high glucose regulates a pro-apoptotic program in retinal pericytes. Diabetes 2002; 51: 2604-2611. (Pubitemid 34729031)
32. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B. Hyperglycaemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001; 50: 2363-2375. (Pubitemid 33641924)
33. Ohtsuka T, Ryu H, Minamishima YA, Macip S, Sagara J, Nakayama KI. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6: 121-128. (Pubitemid 38425711)
34. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diab Rev 2005; 1: 287-298.
35. Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications. Kidney Int 2000; 58: S26-S30. (Pubitemid 30681187)
36. Hammes HP, Du X, Edelstein D, et al.Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-299. (Pubitemid 36362784)
37. Berrone E, Beltramo E, Solimine C, Ubertalli-Ape A, Porta M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 2006; 281: 9307-9313. (Pubitemid 43864646)
38. Wu S, Ren J. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci Lett 2006; 394: 158-162. (Pubitemid 43061479)
39. Ceylan-Isik AF,Wu S, Li Q, Li SY, Ren J. High-dose benfotiamine rescues cardiomyocyte contractile dysfunction in streptozotocin-induced diabetes mellitus. J Appl Physiol 2006; 100: 150-156. (Pubitemid 43671102)